Albany Medical College   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Albany NY United States (1839)

Organization Overview

First Clinical Trial
1994
NCT00002578
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Adam Howe, MD | Albany Medcial Center | Albany Medical Center IRB | Albany Medical College | Albany Medical College Department of Emergency Medicine | Albany Medical CollegeDivision of Allergy, Asthma, & Immunology | Albany Medical , NY 12208, USA | Anica Crnkovic | Attending Surgeon | Neurosciences Institute, Albany Medical College | Parkinson's Disease and Movement Disorder Center of Albany Medical Center | Paul Sorum, MD

Active Ingredients

Drugs in Phase 4 Trials (26)

acetaminophen (tylenol) (3 trials)

bupivacaine (Exparel) (1 trial)

calcium (1 trial)

fentanyl (Innovar) (1 trial)

gabapentin (neurontin) (1 trial)

galantamine (reminyl) (1 trial)

garlic (1 trial)

hydrocodone (hycodan) (2 trials)

ibuprofen (motrin) (4 trials)

ketamine (ketalar) (1 trial)

ketorolac (acuvail) (2 trials)

labetalol (trandate) (2 trials)

levobupivacaine (chirocaine) (3 trials)

milnacipran (savella) (1 trial)

morphine (1 trial)

omalizumab (xolair) (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

orlistat (xenical) (1 trial)

procaine benzylpenicillin (novocaine) (2 trials)

remifentanil (ultiva) (1 trial)

roflumilast (daliresp) (1 trial)

sevelamer (renagel) (1 trial)

sodium chloride (2 trials)

tranexamic acid (cyklokapron) (2 trials)

urea (2 trials)

ziconotide (prialt) (1 trial)

Drugs in Phase 3 Trials (9)

calfactant (infasurf) (2 trials)

cefoxitin (mefoxin) (1 trial)

ceftaroline fosamil (teflaro) (1 trial)

corticotropin (acthar) (2 trials)

daunorubicin (cerubidine) (1 trial)

doxorubicin (Doxil) (2 trials)

lidocaine (xylocaine) (1 trial)

piperacillin (pipracil) (1 trial)

tazobactam (Zosyn) (1 trial)

Drugs in Phase 2 Trials (16)

123i-beta-cit (1 trial)

aldesleukin (Proleukin) (1 trial)

anastrozole (arimidex) (1 trial)

atorvastatin (lipitor) (1 trial)

azd-2066 (1 trial)

celecoxib (celebrex) (1 trial)

clomifene (clomid) (1 trial)

cytarabine (cytosar-u) (1 trial)

daclizumab (Zenapax) (1 trial)

eniluracil (1 trial)

fluorouracil (efudex) (2 trials)

gallium nitrate (ganite) (1 trial)

leucovorin (1 trial)

metformin (glucophage) (1 trial)

naltrexone (revia) (1 trial)

valsartan (diovan) (1 trial)

Drugs in Phase 1 Trials (3)

altretamine (hexalen) (1 trial)

etoposide (vepesid) (1 trial)

oxaliplatin (eloxatin) (1 trial)

Drugs in Other Trials (4)

benzoyl peroxide (clearasil) (1 trial)

clavulanate (Augmentin) (1 trial)

duloxetine (Cymbalta) (1 trial)

simethicone (IMODIUM) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arteriovenous Fistula (Phase 2)

Colorectal Neoplasms (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Diabetic Neuropathies (Phase 2)

Disease (Phase 4)

Esophageal Neoplasms (Phase 1)

Eunuchism (Phase 2)

Fibromyalgia (Phase 4)

Fistula (Phase 2)

Hypercalcemia (Phase 3)

Hypertension (Phase 4)

Hypogonadism (Phase 2)

Intestinal Obstruction (Phase 4)

Kidney Diseases (Phase 4)

Liver Neoplasms (Phase 2)

Lung Diseases (Phase 4)

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Multiple Sclerosis (Phase 2)

Myofascial Pain Syndromes (Phase 4)

Nausea (Phase 4)

Neuralgia (Phase 4)

Otitis Media (Phase 4)

Pain, Postoperative (Phase 4)

Peripheral Nervous System Diseases (Phase 2)

Pharyngitis (Phase 4)

Pneumonia (Phase 3)

Pneumonia, Bacterial (Phase 3)

Postoperative Nausea and Vomiting (Phase 4)

Pre-Eclampsia (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Respiratory Distress Syndrome (Phase 4)

Respiratory Distress Syndrome, Newborn (Phase 4)

Sarcoidosis (Phase 4)

Sarcoma (Phase 3)

Sarcoma, Kaposi (Phase 3)

Sclerosis (Phase 2)

Scoliosis (Phase 4)

Sinusitis (Phase 4)

Syndrome (Phase 4)

Tic Disorders (Phase 4)

Tics (Phase 4)

Toothache (Phase 4)

Tourette Syndrome (Phase 4)

Vascular Calcification (Phase 4)

Vomiting (Phase 4)

Weight Loss (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 49
  • # of Trial APIs: 58